Xenon Corp - XENE Net earnings per share growth forecast for next year

XENE (xenon-pharma.com) - company brandmark

Xenon Pharmaceuticals (XENE) relies on stringent FDA control and unique patent protection. The integration of AI into the synthesis of epilepsy drugs serves as a key driver, confirming the expected EPS change for the coming year. Potential monopoly status will enable the company to exercise significant pricing power over therapy costs, while the -1.70 metric reflects the current dynamics of these expectations.

XENE: Xenon Pharmaceuticals Inc. Expected earnings per share trend next year 07/04/2022 - 11/17/2026

Xenon Pharmaceuticals Inc. - analytical breakdowns and key metrics (XENE)

- issuer market value details:
Comprehensive company analysis:Xenon Corp, XENE
Core merchandise of Xenon

The search for a balance between clinical trial outsourcing costs and future return on capital determines the investment attractiveness of Xenon Pharmaceuticals (XENE). The trend in the company's forward EPS estimates aggregates current analyst earnings-per-share forecasts, enabling the rapid identification of overvalued assets or the undervalued potential for developing new neurological disease treatments, which confirms the financial stability of the business model.

Main competitors

Net earnings per share growth forecast for next year Biogen|Expected earnings per share growth for next year neurocrine.com (NBIX)|Net earnings per share growth forecast for next year Regencell Bioscience Holdings Limited (RGC)|AXSM (Axsome Therapeutics Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Projected earnings per share increase next year VKTX (Viking Pharma)|SUPN: Expected earnings per share growth for next year|Expected earnings per share trend next year CPRX (catalystpharma.com)|DNLI: Earnings growth forecast for next year|HRMY - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year BHVN|AMLX: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Trevi Pharma (TRVI)|Consensus forecast of earnings per share growth for next year praxismedicines.com|Net earnings per share growth forecast for next year Anavex AVXL|Consensus forecast of earnings per share growth for next year CeriBell (CBLL)|PRTA - Net earnings per share growth forecast for next year|ALEC: Net earnings per share growth forecast for next year|Annexon (ANNX) - Net earnings per share growth forecast for next year|OMER: Projected earnings per share increase next year|NGNE (neurogene.com) - Earnings growth forecast for next year|Earnings growth forecast for next year AC Immune S.A.|Expected earnings per share growth for next year VYGR (Voyager Therapeutics, Inc.)|Projected earnings per share increase next year NMRA|Net earnings per share growth forecast for next year scilexholding.com SCLX|TVGN: Projected earnings per share growth rate for next year|alphacognition.com - Earnings growth forecast for next year|Cognition Therapeutics - Projected earnings per share increase next year|IKT: Earnings growth forecast for next year|Expected earnings per share growth for next year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth forecast for next year|Expected earnings per share growth for next year Coya Therapeutics (COYA)|Expected earnings per share growth for next year VTGN (Vistagen)|Consensus forecast of earnings per share growth for next year Ovid Therapeutics Inc|Earnings growth forecast for next year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Expected earnings per share growth for next year|Alterity Therapeutics Limited - Earnings growth forecast for next year|Expected net earnings per share growth next year Clene Inc|PEPG: Earnings growth forecast for next year|Expected earnings per share growth for next year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth forecast for next year|Earnings growth forecast for next year Annovis Bio Corporation|Earnings growth forecast for next year GRCE|AIFF: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Klotho Neurosciences KLTO|NRSN: Projected earnings per share growth rate for next year|RVPH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year MetaVia MTVA|neuraxis.com (NRXS) - Net earnings per share growth forecast for next year|Helius Medical Technologies Inc. - Expected earnings per share trend next year|PASG (Passage Bio, Inc.) - Earnings growth forecast for next year|bionomics.com.au - Net earnings per share change forecast for next year|Earnings growth forecast for next year NERV|ATHA (Athira) - Expected earnings per share trend next year|Addex Therapeutics - Expected earnings per share growth for next year|ALZN - Expected earnings per share growth for next year|Cyclerion Therapeutics, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year CRGT|Expected earnings per share growth for next year ATXI|Expected earnings per share growth for next year Brainstorm Cell (BCLI)|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|Expected earnings per share growth for next year Chromocell Therapeutics Corp CHRO|Earnings growth forecast for next year ELYM (Eliem Therapeutics, Inc.)|Earnings growth forecast for next year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth forecast for next year|NeuroBo Pharmaceuticals Inc - Expected earnings per share trend next year|SAGE (Sage Therapeutics Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year SNPX (Neurotrope)|Net earnings per share growth forecast for next year Trevena Inc. (TRVN)|VIGL - Expected net earnings per share growth next year|Anew Medical Inc. - Expected earnings per share growth for next year|CERE (Cerevel Therapeutics, Inc.) - Net earnings per share change forecast for next year